Athira Pharma Inc Aktie News
0,30 $
1,78 %
gestern
Nasdaq,
13. Juni, 22:00 Uhr
tracken
Athira Pharma Inc Aktie News
Neutral
GlobeNewsWire
●
etwa ein Monat alt
Data from Phase 1 clinical trial of ATH-1105 in healthy volunteers showed a favorable safety and tolerability profile; dose proportional pharmacokinetics and CNS penetration support continued clinical development
Neutral
GlobeNewsWire
●
etwa ein Monat alt
Completed healthy volunteer Phase 1 clinical study of ATH-1105 as a potential treatment for amyotrophic lateral sclerosis (ALS); full healthy volunteer data expected in 2H25
Neutral
GlobeNewsWire
●
4 Monate alt
Completed healthy volunteer Phase 1 clinical study of ATH-1105 as a potential treatment for amyotrophic lateral sclerosis (ALS)
Negativ
GeekWire
●
5 Monate alt
Seattle biotech firm Athira Pharma will pay $4M to settle allegations related to research misconduct
Seattle-area biotech company Athira Pharma agreed to pay $4.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
